Home/Filings/4/0000950170-25-012531
4//SEC Filing

Rajagopalan Harith 4

Accession 0000950170-25-012531

CIK 0001572616other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:04 PM ET

Size

16.3 KB

Accession

0000950170-25-012531

Insider Transaction Report

Form 4
Period: 2025-01-30
Rajagopalan Harith
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Stock Option

    2025-01-3190,97211,564 total
    Exercise: $1.70Exp: 2025-02-10Common Stock (90,972 underlying)
  • Sale

    Common Stock

    2025-01-31$1.82/sh90,972$165,205491,329 total
  • Exercise/Conversion

    Common Stock

    2025-01-30$1.70/sh+20,948$35,612512,277 total
  • Sale

    Common Stock

    2025-01-30$1.95/sh20,948$40,798491,329 total
  • Exercise/Conversion

    Common Stock

    2025-01-31$1.70/sh+90,972$154,652582,301 total
  • Exercise/Conversion

    Stock Option

    2025-01-3020,948102,536 total
    Exercise: $1.70Exp: 2025-02-10Common Stock (20,948 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    18,639
  • Common Stock

    (indirect: By Trust)
    292,170
  • Common Stock

    (indirect: By Trust)
    292,171
Footnotes (4)
  • [F1]Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 12, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9100 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option is fully vested and exercisable.

Documents

1 file

Issuer

FRACTYL HEALTH, INC.

CIK 0001572616

Entity typeother

Related Parties

1
  • filerCIK 0001667672

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:04 PM ET
Size
16.3 KB